Patent Concerns

Direct-to-consumer genetic testing company 23andMe announced earlier this week that it has received its first patent. As our sister publication BioArray News reports, the patent, US Patent No. 8,187,811, covers a method for determining an individual's susceptibility to Parkinson's disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.